Stay updated on Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2. This appears to be a minor software version update with no visible changes to the study details.
    Difference
    0.0%
    Check dated 2026-04-17T13:36:06.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Padua has been replaced with Padova (35128) as the Veneto site name. Padova is now listed as the site location.
    Difference
    0.0%
    Check dated 2026-04-10T08:51:28.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added Naples, Italy 80131 to the locations and removed Napoli, Italy 80131 from the locations.
    Difference
    0.0%
    Check dated 2026-03-26T21:46:50.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.0, replacing the previous revision v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T19:12:38.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3. The previous Revision: v3.4.2 has been removed.
    Difference
    0.0%
    Check dated 2026-03-12T14:48:45.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Fallopian tube cancer is now listed as a condition and the Genetic and Rare Diseases Information Center resource is added; the page version updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-11T23:47:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.